Celebrating 100,000 Safe Man-Hours at Advanced Development and Manufacturing (ADM) Project for Novartis in Holly Springs, North Carolina
September 9, 2014

Novartis Vaccines and Diagnostics, one of the world’s leading pharmaceutical manufacturers, continues to turn to KBR Building Group as it expands its 167-acre campus in Holly Springs, North Carolina – home to the first cell culture-derived influenza vaccines manufacturing complex in the United States.

KBR Building Group broke ground last November on what Novartis refers to as the Advanced Development Manufacturing (ADM) project — an expansion to the company’s planned 460,000-square-foot Holly Springs complex. Three weeks ago, on August 21, KBR Building Group celebrated an important safety milestone on the project — 100,000 safe hours without a lost-time incident. Our team proudly marked the occasion with a worker appreciation luncheon at the project site.

Previous Projects for Novartis Vaccines and Diagnostics
Five years ago, KBR Building Group completed a new 114,298-square-foot Quality Control Laboratory and Administration Building, the architectural focal point for the first phase of Holly Springs campus development. This three-story building, which won several construction industry awards, serves as the central processing facility for both quality control laboratory and administrative functions for Novartis’ local campus operations. KBR Building Group also provided construction management services for the architectural finishes for Novartis’ 38,000-square-foot Facility Operations building. Like the Quality Control Laboratory and Administration Building, this project was part of the initial phase of the Holly Springs campus development.